Rockefeller University Hospital
New York, 10021, United States
Location status: Recruiting
Location contact
Barry Coller, MD
PRINCIPAL_INVESTIGATOR
Recruitment Specialist
CONTACT
NCT Number: NCT00230165
Blood contains red blood cells, white blood cells, and platelets, as well as a fluid portion termed plasma. We primarily study blood platelets, but sometimes we also analyze the blood of patients with red blood cell disorders (such as sickle cell disease), white blood cell disorders, and disorders of the blood clotting factors found in plasma.
Blood platelets are small cell fragments that help people stop bleeding after blood vessels are damaged. Some individuals have abnormalities in their blood platelets that result in them not functioning properly. One such disorder is Glanzmann thrombasthenia. Most such patients have a bleeding disorder characterized by nosebleeds, gum bleeding, easy bruising (black and blue marks), heavy menstrual periods in women, and excessive bleeding after surgery or trauma. Our laboratory performs advanced tests of platelet function and platelet biochemistry. If we find evidence that a genetic disorder may be responsible, we analyze the genetic material (DNA and RNA) from the volunteer, and when possible, close family members to identify the precise defect.
Interested in participating?
Request InfoAll sexes
Observational
New York, 10021, United States
Location status: Recruiting
Barry Coller, MD
PRINCIPAL_INVESTIGATOR
Recruitment Specialist
CONTACT
After volunteers and family members agree to participate, they are seen in the Outpatient Research Center by the Principal Investigator or another physician. A detailed history is obtained, a physical examination is performed, and blood is obtained for further tests. Occasionally patients and family members are requested to return for additional tests. If an abnormality is identified with tests conducted in our research laboratory, we advise the volunteer to have the studies repeated in a laboratory certified to conduct tests on patients.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A. Normal Healthy Volunteers:
B. Patients with Glanzmann thrombasthenia or their relatives, inherited qualitative and/or quantitative platelet disorders, inherited disorders of white blood cells, inherited disorders of coagulation (including von Willebrand disease):
Exclusion criteria
A. Normal Healthy Volunteers:
B. Patients with Glanzmann thrombasthenia or their relatives, inherited qualitative and/or quantitative platelet disorders, inherited disorders of white blood cells, inherited disorders of coagulation (including von Willebrand disease).
Time frame: minutes
The initial slope of the increase in light transmission after an agonist is added to a cuvette containing platelet-rich plasma.
Contact information is provided by the study sponsor or research team.
Rockefeller University
Other
Studies of Interactions Among Normal and Abnormal Blood Cells, and the Vessel Wall, and Studies of Genetic and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell and Coagulation Disorders
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06820515
Anemia, Anemia, Hemolytic
Hickory, North Carolina, United States
View Trial DetailsNCT04119908
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Lille, Nord, France
View Trial DetailsNCT07136857
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Atlanta, Georgia, United States
View Trial DetailsNCT06234813
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Bordeaux, France
View Trial Details